← All Congress trades

SPDR S&P Biotech ETF (XBI) — Congressional Trades

4 U.S. lawmakers have disclosed 9 SPDR S&P Biotech ETF trades under the STOCK Act — 6 buys and 3 sells between 2017 and 2024. Congress has been net buyers of XBI, and their disclosed buys are up 76.0% versus the latest close.

9Trades
6Buys
3Sells
4Members
$156.86Latest close 2026-08-13
+76.0%Congress buys vs latest close*

*Notional-weighted price return on lawmakers' disclosed buys of XBI, marked to the latest close — per-share (share counts aren't disclosed).

67% buys33% sells

Which party is trading XBI?

Republicans
2 buys · 2 sells
3 members · 4 trades
Democrats
3 buys · 1 sells
1 member · 4 trades
DateMemberTypeAmountEst. priceLatest closeReturn
2024-05-08Thomas H TubervilleBUY$1K–$15K$89.11$156.86 2026-08-13+76.0%
2024-05-08Thomas H TubervilleBUY$1K–$15K$89.11$156.86 2026-08-13+76.0%
2023-06-30David P. JoyceSELL$15K–$50K$83.20$156.86 2026-08-13-88.5% exit
2019-09-30James M InhofeSELL$15K–$50K$76.25$156.86 2026-08-13+6.3% rt
2018-12-31James M InhofeBUY$15K–$50K$71.75$156.86 2026-08-13+118.6%
2018-03-09John F ReedSELL$1K–$15K$96.45$156.86 2026-08-13+36.4% rt
2017-06-19John F ReedBUY$1K–$15K$74.16$156.86 2026-08-13+111.5%
2017-03-06John F ReedBUY$1K–$15K$70.73$156.86 2026-08-13+121.8%
2017-03-06John F ReedBUY$1K–$15K$70.73$156.86 2026-08-13+121.8%

Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).

Frequently asked — SPDR S&P Biotech ETF (XBI) congressional trades

Which lawmakers have traded SPDR S&P Biotech ETF (XBI)?

4 members of the U.S. House and Senate have disclosed SPDR S&P Biotech ETF transactions under the STOCK Act — 6 purchases and 3 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.

Which lawmakers bought XBI recently?

No member of Congress has disclosed a XBI purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.

How have Congress's XBI trades performed?

Notional-weighted, lawmakers' disclosed XBI buys are up 76.0% versus the latest close of $156.86. Each trade's own return — and realized round-trips on matched sells — is in the Return column.

Is it legal for members of Congress to trade SPDR S&P Biotech ETF?

Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded XBI and how it performed.

Related stocks — also traded by the same lawmakers

MSFT 3QCOM 3AAPL 3INTC 3OXY 3AMAT 3PEP 3AMGN 3CVS 3CSCO 3KO 3FDX 3ADI 3XOM 3X 2PYPL 2F 2BABA 2